Seminars and Colloquia







Ramille Shah Northwestern University Assistant Professor of Materials Science and Engineering New Biomaterial Platforms for 3D Printing and Their Promise in Medicine
11/02/2016 Zach Serber Zymergen Founder, Chief Science Officer, VP of Development Using data to unravel the dark matter of genomes and improve traits.
12/07/2016 Keith Turner Monsanto Computational Microbiologist Computational biology and data science in the agricultural biotech industry
01/25/2017 Fang Lai Ohmx Corporation Vice Presdient of R&D The Role of Ohmx Platform Technology in the Diagnostic World
02/16/2017 Cato T. Laurencin The University of Connecticuit Professor of Chemical and Biomolecular Engineering, Materials Science and Engineering

Regenerative Engineering: Convergence To Address Grand Challenges

03/15/2017 Alison Mastrangelo Pfizer Associate Research Fellow Globetrotting: How My Engineering Degree Took Me Around the World and How Biosimilars Lured Me Back to the US
03/29/2017 Hal Alper University of Texas Associate Professor of Chemical Engineering Applications of Synthetic Biology and Evolution for Industrial Strain Development
04/05/2017 Latonia Harris The Janssen Pharmaceutical Companies of Johnson & Johnson Scientific Director Accelerated Biopharmaceutical Process Development Case Study:  New Product In-License through Expedited FDA Approval
04/12/2017 Johan Kers Ginkgo Bioworks, Inc. Program Director Making biology easier to engineer:  strategies to design custom microbes for multiple markets using a foundry model
04/19/2017 Jared C. Lewis University of Chicago Assistant Professor of Chemistry Protein engineering, directed evolution, & artificial metalloenzymes
04/26/2017 Heather Pinkett Northwestern University Associate Professor of Molecular Biosciences ATP Binding Cassette (ABC) transporters and their roles in cystic fibrosis, multiple drug resistance and the evolution of superbugs
05/03/2017 Anne Plant National Institute of Standards and Technology Cheif of the Biosystems and Biomaterials Division Advancing rigorous quantitation of biological systems for better understanding and prediction of cell-based and other complex therapies
05/10/2017 David Giljohann Chief Executive Officer Exicure Biotherapeutics development, including regulatory aspects
05/17/2017 Steve Little University of Pittsburgh Professor & Chair - Chemical and Petroleum Engineering; Professor of Bioengineering, Immunology, and Ophthalmology Controlling Controlled Release
05/24/2017 Tom Brieva Celgene Cellular Therapeutics Director, New Product Platforms Cell-based pharmaceutical technology: Accomplishments, promise, and challenges
05/31/2017 Stacey Finley University of Southern California Gabilan Assistant Professor of Biomedical Engineering Systems biology approach to developing molecular-detailed computational models of biological processes related to human disease